ARCHIVES

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

This article is from The Cancer Letter archive.

Vol. 06 No. 13 | March 28, 1980

Download PDF Visit The Full Archive

Related Articles

UC Davis Coordinates Asian American Network

September 27, 2002

FDA Forms Office of Combination Products;

January 10, 2003

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002